| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.14 | 0.003 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.078 | 0.1 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.072 | 0.1 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.063 | 0.2 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.06 | 0.2 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.062 | 0.2 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.059 | 0.2 |